Exposure to CSF from sporadic amyotrophic lateral sclerosis patients induces morphological transformation of astroglia and enhances GFAP and S100β expression

Neuroscience Letters

Volumn 473, Issue 1, 2010, Pages 56-61

  Shobha, K ^a   Alladi, P A ^a   Nalini, A ^a   Sathyaprabha, T N ^a   Raju, T R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Amyotrophic lateral sclerosis; Astrocytes; GFAP; Morphological transformation; S100 ; Spinal cord cultures

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN S100B;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL COUNT; CELL CULTURE; CELL STRUCTURE; CELL TRANSFORMATION; CEREBROSPINAL FLUID; CONTROLLED STUDY; HUMAN; IMMUNOFLUORESCENCE; MACROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; SPINAL CORD; TISSUE CULTURE; WESTERN BLOTTING;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ASTROCYTES; EMBRYO, MAMMALIAN; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; NERVE GROWTH FACTORS; RATS; S100 PROTEINS; SPINAL CORD;

EID: 77950629099     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.02.022     Document Type: Article

References (41)

1. Abe K., Pan L.H., Watanabe M., Kato T., Itoyama Y. Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis. Neurosci. Lett. 1995, 199:152-154.
2. Anneser J.M., Cookson M.R., Ince P.G., Shaw P.J., Borasio G.D. Glial cells of the spinal cord and subcortical white matter up-regulate neuronal nitric oxide synthase in sporadic amyotrophic lateral sclerosis. Exp. Neurol. 2001, 171:418-421.
3. Banker G.A. Trophic interactions between astroglial cells and hippocampal neurons in culture. Science 1980, 209:809-810.
4. Baudier J., Delphin C., Grunwald D., Khochbin S., Lawrence J.J. Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:11627-11631.
5. Beal M.F., Ferrante R.J., Browne S.E., Matthews R.T., Kowall N.W., Brown R.H. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 1997, 42:644-654.
6. Bhattacharyya A., Oppenheim R.W., Prevette D., Moore B.W., Brackenbury R., Ratner N. S100 is present in developing chicken neurons and Schwann cells and promotes motor neuron survival in vivo. J. Neurobiol. 1992, 23:451-466.
7. Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000, 1:293-299.
8. Bruijn L.I., Becher M.W., Lee M.K., Anderson K.L., Jenkins N.A., Copeland N.G., Sisodia S.S., Rothstein J.D., Borchelt D.R., Price D.L., Cleveland D.W. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 1997, 18:327-338.
9. Cassina P., Peluffo H., Pehar M., Martinez-Palma L., Ressia A., Beckman J.S., Estevez A.G., Barbeito L. Peroxynitrite triggers a phenotypic transformation in spinal cord astrocytes that induces motor neuron apoptosis. J. Neurosci. Res. 2002, 67:21-29.
10. Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boillee S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J., Brown R.H., Julien J.P., Goldstein L.S., Cleveland D.W. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003, 302:113-117.
11. Eagleson K.L., Raju T.R., Bennett M.R. Motoneurone survival is induced by immature astrocytes from developing avian spinal cord. Brain Res. 1985, 349:95-104.
12. Faulkner J.R., Herrmann J.E., Woo M.J., Tansey K.E., Doan N.B., Sofroniew M.V. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 2004, 24:2143-2155.
13. Griffin W.S., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White C.L., Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:7611-7615.
14. Hewett S.J., Csernansky C.A., Choi D.W. Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. Neuron 1994, 13:487-494.
15. Howland D.S., Liu J., She Y., Goad B., Maragakis N.J., Kim B., Erickson J., Kulik J., DeVito L., Psaltis G., DeGennaro L.J., Cleveland D.W., Rothstein J.D. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc. Natl. Acad. Sci. U.S.A. 2002, 99:1604-1609.
16. Hu J., Ferreira A., Van Eldik L.J. S100beta induces neuronal cell death through nitric oxide release from astrocytes. J. Neurochem. 1997, 69:2294-2301.
17. MacVicar B.A. Morphological differentiation of cultured astrocytes is blocked by cadmium or cobalt. Brain Res. 1987, 420:175-177.
18. Maihofner C., Probst-Cousin S., Bergmann M., Neuhuber W., Neundorfer B., Heuss D. Expression and localization of cyclooxygenase-1 and -2 in human sporadic amyotrophic lateral sclerosis. Eur. J. Neurosci. 2003, 18:1527-1534.
19. McCaffery C.A., Raju T.R., Bennett M.R. Effects of cultured astroglia on the survival of neonatal rat retinal ganglion cells in vitro. Dev. Biol. 1984, 104:441-448.
20. Migheli A., Cordera S., Bendotti C., Atzori C., Piva R., Schiffer D. S-100beta protein is upregulated in astrocytes and motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis. Neurosci. Lett. 1999, 261:25-28.
21. Millward T.A., Heizmann C.W., Schafer B.W., Hemmings B.A. Calcium regulation of Ndr protein kinase mediated by S100 calcium-binding proteins. EMBO J. 1998, 17:5913-5922.
22. Monnerie H., Esquenazi S., Shashidhara S., Le Roux P.D. Beta-amyloid-induced reactive astrocytes display altered ability to support dendrite and axon growth from mouse cerebral cortical neurons in vitro. Neurol. Res. 2005, 27:525-532.
23. Mrak R.E., Sheng J.G., Griffin W.S. Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 1996, 55:273-279.
24. Muramatsu Y., Kurosaki R., Watanabe H., Michimata M., Matsubara M., Imai Y., Araki T. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice. Glia 2003, 42:307-313.
25. Nedergaard M. Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science 1994, 263:1768-1771.
26. Parpura V., Basarsky T.A., Liu F., Jeftinija K., Jeftinija S., Haydon P.G. Glutamate-mediated astrocyte-neuron signalling. Nature 1994, 369:744-747.
27. Pedersen W.A., Fu W., Keller J.N., Markesbery W.R., Appel S., Smith R.G., Kasarskis E., Mattson M.P. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann. Neurol. 1998, 44:819-824.
28. Ramamohan P.Y., Gourie-Devi M., Nalini A., Shobha K., Ramamohan Y., Joshi P., Raju T.R. Cerebrospinal fluid from amyotrophic lateral sclerosis patients causes fragmentation of the Golgi apparatus in the neonatal rat spinal cord. Amyotroph. Lateral Scler. 2007, 8:79-82.
29. Sasaki S., Shibata N., Komori T., Iwata M. iNOS and nitrotyrosine immunoreactivity in amyotrophic lateral sclerosis. Neurosci. Lett. 2000, 291:44-48.
30. Schiffer D., ordera S., Cavalla P., Migheli A. Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis. J. Neurol. Sci. 1996, 139(Suppl.):27-33.
31. Schulz M., Raju T., Ralston G., Bennett M.R. A retinal ganglion cell neurotrophic factor purified from the superior colliculus. J. Neurochem. 1990, 55:832-841.
32. Shahani N., Nalini A., Gourie-Devi M., Raju T.R. Reactive astrogliosis in neonatal rat spinal cord after exposure to cerebrospinal fluid from patients with amyotrophic lateral sclerosis. Exp. Neurol. 1998, 149:295-298.
33. Sheng J.G., Mrak R.E., Griffin W.S. S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques. J. Neurosci. Res. 1994, 39:398-404.
34. Shobha K., Vijayalakshmi K., Alladi P.A., Nalini A., Sathyaprabha T.N., Raju T.R. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients. J. Neurol. Sci. 2007, 254:9-16.
35. Strong M.J. The basic aspects of therapeutics in amyotrophic lateral sclerosis. Pharmacol. Ther. 2003, 98:379-414.
36. Szatkowski M., Barbour B., Attwell D. Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature 1990, 348:443-446.
37. Tacconi M.T. Neuronal death: is there a role for astrocytes?. Neurochem. Res. 1998, 23:759-765.
38. Takahashi M., Billups B., Rossi D., Sarantis M., Hamann M., Attwell D. The role of glutamate transporters in glutamate homeostasis in the brain. J. Exp. Biol. 1997, 200:401-409.
39. Van Eldik L.J., Griffin W.S. S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions. Biochim. Biophys. Acta 1994, 1223:398-403.
40. Vijayalakshmi K., Alladi P.A., Sathyaprabha T.N., Subramaniam J.R., Nalini A., Raju T.R. Cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients induces degeneration of a cultured motor neuron cell line. Brain Res. 2009, 1263:122-133.
41. Wang L.J., Lu Y.Y., Muramatsu S., Ikeguchi K., Fujimoto K., Okada T., Mizukami H., Matsushita T., Hanazono Y., Kume A., Nagatsu T., Ozawa K., Nakano I. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. J. Neurosci. 2002, 22:6920-6928.